GLP-1 Companion Nutrition at Vitafoods Europe 2026 Vitafoods Europe 2026, held May 5 to 7 in Barcelona, made GLP-1 companion nutrition one of its defining themes, with dedicated conference sessions and a wave of ingredient launches aimed squarely at the muscle, satiety, and nutrient-adequacy problems above [14, 15]
In case REE or TEE could not be measured, 2530 kcal/kg/day with 1.2-1.5 g/protein/kg/day could be considered as proper ranges to maintain or restore lean body mass (64)
A GWAS in 2,153 Mexican children and adults used a Mendelian randomization approach to assess whether genetic variants that modify serum UA level were associated with premature CAD
Understanding your genetic predispositions can support a more personalized conversation with your provider about optimizing semaglutide injection timing, dose escalation pace, and tolerability managementmoving beyond generic recommendations toward a strategy tailored to your unique physiology
For example, certain GLP1R variants may correlate with baseline receptor sensitivity, while GIPR variants relate to glucose-dependent insulinotropic peptide signaling
Clinical Relevance and Human Trials Clinical trials have explored the administration of BPC 157 at a dosage of 200 g per person per day via intramuscular injection for a duration of 7 days
